CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer (Q37725026)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 2010
edit
Language Label Description Also known as
English
CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer
scientific article published on May 2010

    Statements

    CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit